Clinical Trial Update: A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effects of JNJ-26489112 on photic-induced paroxysmal EEG responses in patients with photosensitive epilepsy; the trial status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photosensitive Epilepsy

Drugs mentioned

• JNJ-26489112

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Photosensitive Epilepsy | Phase 2 | Status: COMPLETED